Unless you experience unmanageable side effects, you can keep increasing your dose every 4 weeks until the maximum maintenance dose is reached
KPV (Lysine-Proline-Valine): A C-terminal tripeptide of alpha-MSH, researched for potent anti-inflammatory and antimicrobial properties
The estrus cycle is judged by the following: Proestrus, mainly composed of nuclear epithelial cells
Phillip M
Summary Clinical Presentation More common in people with darker skin Correlates with the configuration and distribution of the causative inflammatory dermatosis Causes include inflammatory conditions, cutaneous injuries, irritants, or burns Histologic Features Decrease melanin of the basal keratinocytes Upper dermal/submucosal melanophages Sparse superficial lymphohistiocytic inflammation Inflammatory cause may be coexisting Differential Diagnosis Sarcoidosis Lichen sclerosus Hypopigmented mycosis fungoides Hypopigmented extramammary Pagets disease Hypopigmentation after medication Vitiligo Chemical leukoderma Takeaway Essentials Clinical Relevant Pearls Correlates with distribution of the causative inflammatory dermatosis Pathology Interpretation Pearls Decreased melanin of the basal keratinocytes Upper dermal/submucosal melanophages Immunohistochemical/Molecular Findings Fontana-Masson special stain may show decreased melanization of basal keratinocytes Immunohistochemical melanocytic markers (MITF, HMB45, etc.) may show a decreased number of melanocytes Vitiligo Clinical Features Vitiligo, an acquired leukoderma, is one of the most frequent disorders of pigmentation of the skin and is characterized by distinct areas of skin and mucous membranes depigmentation
and clear escalation protocols for adverse events
